REG - Leverage Shares PLC Leverage 3XLong Ant$ Leverage 3XLong Ant£ Leverage 3XLong Ant€ - Market Notification - 3x Anthropic -Cash Portfolio
Leverage Shares plc
12 November 2026
Notice in respect of Leverage Shares 3x Long Anthropic ETP
(ISIN: XS3556798455) (the “Relevant Series”)
Leverage Shares plc (the “Issuer”) hereby announces that, following the admission to trading of the Relevant Series on the London Stock Exchange on 13 November 2026, the portfolio of the Relevant Series will be comprised only of cash until further notice.
The Relevant Series pursues the Leveraged Anthropic Investment Strategy, a Leveraged Exposure Post-IPO Investment Strategy which aims to provide, following the IPO, a daily Leveraged Exposure of 3x to the Underlying Entity Shares of Anthropic, PBC (the “Underlying Entity”).
Until the IPO, the Relevant Series will be in the Initial Phase, during which it will provide no exposure of any kind to the Underlying Entity. The issue proceeds will be held in cash in the Margin Account and will accrue the Return on Collateral, and no Arranger Fee will be charged.
The Initial Phase may last for a significant period of time, and there can be no assurance as to when, or whether, the IPO will occur.
The Issuer will publish a further announcement confirming the date on which it intends to offer the Leveraged Exposure to the Underlying Entity and the applicable Leverage Factor.
Capitalised terms used, but not defined, in this notice shall have the meaning given thereto in the Issuer’s Base Prospectus as approved by the Financial Conduct Authority on 2 November 2026.
If you have any queries arising from this notice, please contact us at info@leverageshares.com.
Yours sincerely
The Directors
Leverage Shares plc
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END MSCEALFAFSSKFFA